HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Idraparinux for stroke prevention in atrial fibrillation.

AuthorsClaudia Stöllberger, Josef Finsterer
JournalThe Lancet. Neurology (Lancet Neurol) Vol. 7 Issue 4 Pg. 290-1 (Apr 2008) ISSN: 1474-4422 [Print] England
PMID18339343 (Publication Type: Letter)
Chemical References
  • Fibrinolytic Agents
  • Oligosaccharides
  • idraparinux
Topics
  • Atrial Fibrillation (complications)
  • Fibrinolytic Agents (therapeutic use)
  • Humans
  • Oligosaccharides (therapeutic use)
  • Stroke (etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: